← FDA Drug Approvals (Drugs@FDA)
TREPROSTINIL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ACTAVIS LABS · Approved 2023-04-03
Drug application
- FDA Application #
ANDA208906- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TREPROSTINIL
- Generic name
- Treprostinil
- Active ingredients
- TREPROSTINIL
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- ACTAVIS LABS
- First approval
- 2023-04-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown